OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation of beta-amyloid production in neurons by astrocyte-derived cholesterol
Hao Wang, Joshua A. Kulas, Chao Wang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 33
Open Access | Times Cited: 220

Showing 1-25 of 220 citing articles:

Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects
Femke M. Feringa, Rik van der Kant
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 161

The role of high cholesterol in age-related COVID19 lethality
Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 140

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 140

Lipid accumulation induced by APOE4 impairs microglial surveillance of neuronal-network activity
Matheus B. Victor, Noelle Leary, Xochitl Luna, et al.
Cell stem cell (2022) Vol. 29, Iss. 8, pp. 1197-1212.e8
Open Access | Times Cited: 139

Brain cell type-specific cholesterol metabolism and implications for learning and memory
Dingfeng Li, Juan Zhang, Qiang Liu
Trends in Neurosciences (2022) Vol. 45, Iss. 5, pp. 401-414
Closed Access | Times Cited: 87

Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 80

Machine Learning for Dementia Prediction: A Systematic Review and Future Research Directions
Ashir Javeed, Ana Luiza Dallora, Johan Berglund, et al.
Journal of Medical Systems (2023) Vol. 47, Iss. 1
Open Access | Times Cited: 79

Microneedle-mediated nose-to-brain drug delivery for improved Alzheimer's disease treatment
Shuyao Ruan, Jiaqi Li, Hang Ruan, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 712-731
Closed Access | Times Cited: 21

Lipid Rafts in Signalling, Diseases, and Infections: What Can Be Learned from Fluorescence Techniques?
Sara Anselmo, Elisa Bonaccorso, Chiara M. A. Gangemi, et al.
Membranes (2025) Vol. 15, Iss. 1, pp. 6-6
Open Access | Times Cited: 1

Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
Ze‐Hu Sheng, Linlin Wang, Ming Chen, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1

Astrocyte immunometabolic regulation of the tumour microenvironment drives glioblastoma pathogenicity
Rita Perelroizen, Bar Philosof, Noga Budick-Harmelin, et al.
Brain (2022) Vol. 145, Iss. 9, pp. 3288-3307
Open Access | Times Cited: 55

CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels
Marta del Campo, Carel F.W. Peeters, Erik C. B. Johnson, et al.
Nature Aging (2022) Vol. 2, Iss. 11, pp. 1040-1053
Open Access | Times Cited: 52

Diabetes and hypertension are related to amyloid-beta burden in the population-based Rotterdam Study
Joyce van Arendonk, Julia Neitzel, Rebecca M. E. Steketee, et al.
Brain (2022) Vol. 146, Iss. 1, pp. 337-348
Open Access | Times Cited: 48

Chimeric cerebral organoids reveal the essentials of neuronal and astrocytic APOE4 for Alzheimer’s tau pathology
Shichao Huang, Zhen Zhang, Jun-Wei Cao, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 41

Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture
Zixuan Yuan, Mahmud Arif Pavel, Hao Wang, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 37

Inflammasome activation under high cholesterol load triggers a protective microglial phenotype while promoting neuronal pyroptosis
Cristina de Dios, Xenia Abadin, Vicente Roca‐Agujetas, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 36

The role of high cholesterol in SARS-CoV-2 infectivity
Hao Wang, Zixuan Yuan, Mahmud Arif Pavel, et al.
Journal of Biological Chemistry (2023) Vol. 299, Iss. 6, pp. 104763-104763
Open Access | Times Cited: 33

Cholesterol Metabolism in Aging and Age-Related Disorders
Gesine Saher
Annual Review of Neuroscience (2023) Vol. 46, Iss. 1, pp. 59-78
Open Access | Times Cited: 29

The Promise of Niacin in Neurology
Emily Wuerch, Gloria Roldan Urgoiti, V. Wee Yong
Neurotherapeutics (2023) Vol. 20, Iss. 4, pp. 1037-1054
Open Access | Times Cited: 28

The Amyloid-Beta Clearance: From Molecular Targets to Glial and Neural Cells
Wenjun Cai, Tong Wu, Ning Chen
Biomolecules (2023) Vol. 13, Iss. 2, pp. 313-313
Open Access | Times Cited: 26

Caenorhabditis elegans as a Model System to Study Human Neurodegenerative Disorders
Antonis Roussos, Katerina Kitopoulou, Fivos Borbolis, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 478-478
Open Access | Times Cited: 26

Loss of insulin signaling in astrocytes exacerbates Alzheimer-like phenotypes in a 5xFAD mouse model
Wenqiang Chen, Qian Huang, Ekaterina Lazdon, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 21
Open Access | Times Cited: 25

Astrocytic modulation of neuronal signalling
Sushmitha S. Purushotham, Yossi Buskila
Frontiers in Network Physiology (2023) Vol. 3
Open Access | Times Cited: 25

Page 1 - Next Page

Scroll to top